Shelton Capital Management Amgen Inc Transaction History

Shelton Capital Management

$3.43 Billion
Q1 2024

A detailed history of Shelton Capital Management transactions in Amgen Inc stock. As of the latest transaction made, Shelton Capital Management holds 77,644 shares of AMGN stock, worth $24.3 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

77,644

Previous 82,689 6.1%

Holding current value

$24.3 Million

Previous $23.8 Million 7.31%

% of portfolio

0.64%

Previous 0.76%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $1.36 Million - $1.64 Million	-5,045 Reduced 6.1%	77,644 $22.1 Million
Q4 2023 Feb 14, 2024	SELL	$255.7 - $288.46 $856,339 - $966,052	-3,349 Reduced 3.89%	82,689 $23.8 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $4.05 Million - $5.02 Million	18,510 Added 27.41%	86,038 $23.1 Million
Q2 2023 Aug 10, 2023	BUY	$214.27 - $253.37 $2.43 Million - $2.87 Million	11,346 Added 20.2%	67,528 $15 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $3.18 Million - $3.88 Million	14,093 Added 33.48%	56,182 $13.6 Million

Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $3.16 Million - $4.02 Million	-13,801 Reduced 24.69%	42,089 $11.1 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $381,357 - $430,101	-1,699 Reduced 2.95%	55,890 $12.6 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $69,213 - $77,022	-300 Reduced 0.52%	57,589 $14 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $10,305 - $11,400	47 Added 0.08%	57,889 $14 Million
Q4 2021 Feb 11, 2022	BUY	$198.88 - $227.6 $218,569 - $250,132	1,099 Added 1.94%	57,842 $13 Million
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $22,500 - $26,362	-106 Reduced 0.19%	56,743 $12.1 Million
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $2.1 Million - $2.33 Million	-9,000 Reduced 13.67%	56,849 $13.9 Million
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $779,569 - $908,461	3,513 Added 5.64%	65,849 $16.4 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $47,603 - $56,687	-220 Reduced 0.35%	62,336 $14.3 Million
Q3 2020 Nov 09, 2020	SELL	$234.65 - $260.95 $23,699 - $26,355	-101 Reduced 0.16%	62,556 $15.9 Million
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $1.61 Million - $1.98 Million	8,162 Added 14.98%	62,657 $14.8 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $248,393 - $329,437	-1,363 Reduced 2.44%	54,495 $11 Million
Q4 2019 Feb 11, 2020	SELL	$189.21 - $243.2 $370,851 - $476,672	-1,960 Reduced 3.39%	55,858 $13.5 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $1.8 Million - $2.16 Million	-10,354 Reduced 15.19%	57,818 $11.2 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $9.17 Million - $10.8 Million	55,033 Added 418.85%	68,172 $12.6 Million
Q1 2019 May 10, 2019	SELL	$180.87 - $203.88 $10.2 Million - $11.5 Million	-56,387 Reduced 81.1%	13,139 $69.2 Million
Q4 2018 Jan 31, 2019	SELL	$178.4 - $208.25 $1.1 Million - $1.28 Million	-6,164 Reduced 8.14%	69,526 $13.5 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $448,216 - $505,304	-2,419 Reduced 3.1%	75,690 $15.7 Million
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $3.17 Million - $3.57 Million	-19,117 Reduced 19.66%	78,109 $14.4 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $415,103 - $485,100	2,450 Added 2.59%	97,226 $16.6 Million
Q4 2017 Feb 06, 2018	BUY	$168.79 - $188.59 $3.79 Million - $4.24 Million	22,483 Added 31.1%	94,776 $16.5 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $469,917 - $536,519	2,809 Added 4.04%	72,293 $13.5 Million
Q2 2017 Aug 14, 2017	BUY	N/A	5,913 Added 9.3%	69,484 $12 Million
Q1 2017 Nov 28, 2017	BUY	N/A	3,928 Added 6.59%	63,571 $10.4 Million
Q4 2016 Nov 29, 2017	SELL	N/A	-200 Reduced 0.33%	59,643 $8.72 Million
Q3 2016 Dec 06, 2017	BUY	N/A	200 Added 0.34%	59,843 $9.98 Million
Q3 2016 Dec 04, 2017	BUY	N/A	59,643	59,643 $8.72 Million

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Shelton Capital Management with notifications on news.

Account

Shelton Capital Management Amgen Inc Transaction History